Hospira Patents – Insights & Stats (Updated 2023)

Hospira has a total of 1056 patents globally, out of which 474 have been granted. Of these 1056 patents, more than 23% patents are active. United States of America is where Hospira has filed the maximum number of patents, followed by Europe and Australia. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Hospira.

Hospira was founded in the year 2004. The Company manufactures and sells generic pharmaceutical products.

Do read about some of the most popular patents of Hospira which have been covered by us in this article and also you can find Hospira patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Hospira patent portfolio.

How many patents does the founder of Hospira have?

The founder Martin Mugume Namani has 0 patent.

How many patents does Hospira have?

Hospira has a total of 1056 patents globally. These patents belong to 250 unique patent families. Out of 1056 patents, 247 patents are active.

How Many Patents did Hospira File Every Year?

Hospira Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantHospira Applications FiledHospira Patents Granted
202312
20223
202137
20201213
20191926
20181543
20171038
2016926
20153424
20143132
20136623
201214420

Which Hospira Drug Patents are Expiring in the Next 10 Years?

The patent no. US9320712B2 which is expiring in Jan, 2032, describing the disclosure involves pharmaceutical compositions containing dexmedetomidine or its salt formulated as a liquid for injecting into a patient. The composition is pre-mixed and stored in a sealed container. These compositions are useful in tasks like perioperative care or sedation of patients.

Given below is the list of few drugs patented by Hospira accompanied by a patent relevant to the drug which will be available for generic drug manufacturing and usage within the next/upcoming 10 years for treatment of various diseases and disorders.

Drug NamePatent NumberPatent TitlePatent Expiration
PrecedexUS9320712B2Dexmedetomidine premix formulationJan, 2032
DaptomycinUS9655946B2Daptomycin formulations and uses…Sep, 2033
DylojectUS8946292B2Formulations of low dose diclofenac…Mar, 2027

How many Hospira patents are Alive/Dead?

Hospira Patent Portfolio

 How Many Patents did Hospira File in Different Countries?

Hospira Worldwide Patent Filing

Countries in which Hospira Filed Patents

CountryPatents
United States Of America139
Europe138
Australia102
Japan99
Canada66
Germany57
Austria55
Spain33
Hong Kong (S.A.R.)24
India20
Korea (South)18
China18
Mexico16
Denmark11
Israel11
Brazil10
New Zealand9
Singapore9
Portugal8
Slovenia6
Estonia6
Slovakia6
Malaysia6
Norway6
Hungary5
South Africa5
Taiwan4
Poland4
Saudi Arabia4
Indonesia4
Cyprus4
Croatia3
Turkey3
Viet Nam3
Serbia2
Lithuania2
Argentina2
Peru2
Chile2
Philippines2
Albania2
United Kingdom2
Malta2
Colombia1
Uruguay1
Ecuador1
Tunisia1
Morocco1
Brunei1
United Arab Emirates1
Italy1

Where are Research Centres of Hospira Patents Located?

R&D Centers of Hospira

 10 Best Hospira Patents

US6388393B1 is the most popular patent in the Hospira portfolio. It has received 154 citations so far from companies like Intravena, Icu Medical and Becton Dickinson and Company Limited.

Below is the list of 10 most cited patents of Hospira:

Publication NumberCitation Count
US7758560B2154
US20100280486A1153
US20100114027A1120
US6561224B1117
US6524295B291
US6695829B289
US20040162263A184
US8221382B281
US7273889B276
US8091727B275

How many inventions of other companies were rejected due to Hospira patents?

The statistics below share strategic R&D insights. It tells the companies that were trying to protect inventions similar to Hospira invention. They couldn’t because Hospira had protected those before them.

Examiners at the USPTO referred 51 Hospira patents in 247 rejections (35 USC § 102 or 35 USC § 103 types).

The top citing companies in the Hospira patent portfolio are Jpmorgan Chase Bank, Fresenius Kabi Deutschland and Zhejiang Medicine.

List of the Companies whose Patents were rejected citing Hospira –

CompanyNumber of Patent Applications that faced Rejection Citing Hospira PatentsNumber of Rejections (102 & 103)
Jpmorgan Chase Bank510
Fresenius Kabi Deutschland59
Zhejiang Medicine38
Gruenenthal34
Deka Products35
Carmel Pharma23
Hq Specialty Pharma23
Sanofi-Aventis Deutschland29
Crisi Medical Systems211
IBM27

Count of 102 and 103 Type Rejections based on Hospira Patents

 Top Hospira Patents used in Rejecting Most Patent Applications

Patent NumberCount of Rejected Applications
US6942473B27
US8709310B26
US7530974B25
US20040138298A15
US6613036B15
US7488311B24
US7563253B24
US20040073192A14
US7273889B24
US6716867B14
US7717897B23
US7527619B23
US8091727B23
US6561224B13
US20100280486A13

What are Hospira key innovation segments?

What Technologies are Covered by Hospira?

The chart below distributes patents filed by Hospira in different countries on the basis of the technology protected in patents. It also represents the markets where Hospira thinks it’s important to protect particular technology inventions.

R&D Focus: How has Hospira search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Hospira?

Related Articles

Weo Llc Patents – Insights & Stats (Updated 2024)

Weo Llc has a total of 47 patents globally, out of which 9 have been granted. Of these 47 patents, more than 87% patents are active. The United States of America is where Weo Llc has filed the maximum number of patents, followed by Brazil and Australia. Parallelly, France seems

Read More »

Fortephest Patents – Insights & Stats (Updated 2024)

Fortephest has a total of 23 patents globally. Of these 23 patents, more than 91% patents are active. Argentina is where Fortephest has filed the maximum number of patents, followed by New Zealand and Australia. Parallelly, The United States of America seems to be the main focused R&D center and

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.